9 October 2026 CPHI Milan 2026: Conversations Moving Forward Farmak International concluded three intensive days at CPHI Milan 2026 with strong partner interest in complex generics, injectables, and future collaboration.
1 October 2026 Farmak International Reaches Key R&D Milestone in Paliperidone 1-Monthly LAI Development Farmak International has reached an important R&D milestone in its development program for of Paliperidone 1-monthly long-acting injection (LAI)
11 September 2026 Farmak International Completes 17 Launches Across 9 Markets This Summer From June to August 2026, Farmak International completed 17 product launches and re-launches across 9 countries.
30 July 2026 ICM Farmak Expands Its Authorized Activities in Spain ICM Farmak S.L.U., Farmak International’s sterile injectables manufacturing site in Spain, has received an updated certificate from the Spanish Agency of Medicines and Medical Devices (AEMPS), reflecting an expanded scope of authorized activities.
30 July 2026 ICM Farmak Expands GMP-Certified Capabilities with In-House Sterility Testing ICM Farmak S.L.U., Farmak International’s manufacturing site in Spain, has received authorization from the Spanish Agency of Medicines and Medical Devices (AEMPS) to perform microbiological sterility testing within its own quality control laboratories.
